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JAMES FOSSE (D2815-1)

New Discovery Makes
Detecting
Johne’s
Disease
Easier
Before a disease can be
treated, it must first be
identified. But that’s not always

easy, especially in the case of Johne’s
disease, which affects cattle, sheep, goats,
deer, and other ruminants.
Johne’s disease—also known as “paratuberculosis”—is a costly, contagious
disease that causes diarrhea, reduced feed
intake, weight loss, and sometimes death.
Annual estimated losses to cattle producers
range from $40 to $227 per infected animal.
For the U.S. dairy industry alone, losses
exceed $220 million each year.
For years, scientists have been hampered
by the fact that any antibody—a protein
produced by the immune system to fight
infections and foreign substances—used to
detect the Johne’s disease bacterium also
reacted to other environmental bacteria or
maybe the pathogen responsible for bovine
tuberculosis. This caused false-positive
test results.
“You may think cattle are infected,
based on a positive antibody test result,
but they may simply have been exposed
to nonpathogenic mycobacteria that’s
ubiquitously present in the environment,”
says microbiologist John Bannantine at
the Agricultural Research Service’s National Animal Disease Center (NADC) in
Ames, Iowa.
That problem, however, is now history.
Bannantine and his colleagues at NADC
have found an antibody that’s 100 percent
specific in detecting Mycobacterium avium
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At the National Animal Disease Center, in Ames, Iowa, microbiologists John Bannantine and Judy
Stabel review results of a western blot experiment using the MAP specific monoclonal antibody.

subspecies paratuberculosis (MAP)—the
cause of Johne’s disease.
“No one else in the world has been able
to find such a specific antibody that binds
only to MAP strains, until now,” says
Bannantine, who’s in NADC’s Infectious
Bacterial Diseases Research Unit.
A Wild Goose Chase

After identifying the new antibody—
called “17A12”—from mice immunized
with MAP strain K-10, scientists decided to
dig a little deeper to determine the protein
this novel antibody binds to.
Initially, researchers believed they had
found a new gene encoding the antibodybinding protein that was not originally
identified in the MAP K-10 genome. They
called it “UP1” (Unique Protein 1).

“In 2005, we sequenced the genome of
a MAP cattle strain, and then annotated
it—finding all the genes and identifying
where they start and where they stop,”
Bannantine says. “But the 17A12 antibody
bound to a protein encoded by a gene that
was not annotated in the MAP genome.
This was unusual, but we were excited
about finding a potentially new gene.”

ARS scientists at Ames, Iowa, have discovered a
specific antibody that will help develop a test for
the Johne’s disease bacterium in cattle.
Stephen Ausmus (K11050-8)
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To confirm this unusual finding, Bannantine developed additional monoclonal
antibodies to the UP1 protein. Only one
of these new antibodies reacted with the
native protein produced by MAP. It also
happened to bind to the same area of the
protein as the initial antibody—17A12.
“When we expressed the UP1 protein
in E. coli, it reacted with the monoclonal
antibody, and we saw this as confirmation
that UP1 was real, even though it wasn’t annotated in the genome,” Bannantine says.
Finding the Right Protein

from several paratuberculosis and nonparatuberculosis strains.
He found a single nucleotide change in
the sequence encoding the epitope. This
change affected the first amino acid out of
the seven that make up the epitope, which
is what created the specificity of M. paratuberculosis, Bannantine says.
Researchers can now accurately detect
the Johne’s disease pathogen and know for
certain that it’s not a contaminant.
“We finally have a specific antibody to
detect live mycobacteria in the tissues or
feces of cattle. This could never have been
done before,” Bannantine says.
Scientists have received a patent for the
new antibody and are moving forward to
develop diagnostic tests that will confirm

the presence of the Johne’s disease
bacterium.
“We can now use this antibody to enrich
the bacterium when it is present in low concentrations, such as in unpasteurized milk
samples,” Bannantine says. “Improved
testing and diagnostics is really the big
benefit of this antibody.”—By Sandra
Avant, ARS.
This research is part of Animal Health,
an ARS national program (#103) described
at www.nps.ars.usda.gov.
John Bannantine is in the USDA-ARS
Infectious Bacterial Diseases Research
Unit, National Animal Disease Center,
1920 Dayton Ave., Ames, IA 50010; (301)
337-7340, john.bannantine@ars.usda.
gov.

But some of the data just didn’t add up.
After additional experiments, it turned out
that UP1 was not a real gene after all.
“It completely blew my mind. I had
never had a day in the lab like that where
there was such a revelation,” Bannantine says. “When we first got
the results contradicting UP1 as
Examining Johne’s Vaccines and Bovine TB Tests for Cross Reaction
a real gene, it was scary because
we thought we had made some
Vaccines play a critical role in reducing the severity of Johne’s disease, but using
big mistakes. Then slowly all the
them can become a balancing act if the vaccine cross-reacts with tests for other
pieces started to fit together, and
cattle diseases like bovine tuberculosis (TB)—an issue in states where wildlife are
we knew what we actually had.
tracking TB back into dairy herds.
It was incredible.”
“Producers are concerned that if they vaccinate against Johne’s, they will not be
Although UP1 was not a gene,
able to discriminate whether their herd has bovine tuberculosis or Johne’s,” says
it had an epitope—a portion of a
microbiologist Judy Stabel, in the National Animal Disease Center’s Infectious
molecule to which an antibody
Bacterial Disease Research Unit.
binds. This epitope mimicked a
Stabel looked at the cross reactivity of an effective U.S. commercial vaccine with
similar epitope in the real gene.
TB diagnostic tests. Several calves were vaccinated against Johne’s disease,
In fact, Bannantine says, out of
and blood samples were taken over a period of 1 year. Immune and serological
the seven amino acids that make
responses of calves were then measured using novel TB diagnostics that will be
up the epitope in UP1, one amino
available in the future.
acid was different from the real
“These new serology tests for TB diagnostics are very promising,” Stabel says.
epitope encoded by MAP1025,
“They’re similar to the stick pregnancy tests for humans, except you use serum.”
a gene that was annotated in the
The tests consist of small sticks coated with bovine TB antigen. The antibody in
MAP genome.
the serum reacts to the antigen if it is positive.
With this new discovery, sciWith vaccinated calves, no reactivity was found using the TB tests, which is good
entists not only found the real
because it means that those tests will not wrongly identify cattle with Johne’s disantibody-binding protein, but
ease as being positive for bovine TB, Stabel says.
could now focus on the reason
“We also did skin testing, which is one of the main tests in the field for bovine tuwhy the new antibody was so
berculosis, and found similar results,” she adds.
specific to MAP.
The results of these studies showed that calves could be vaccinated against Johne’s
Solving the Mystery of
disease without interfering with bovine TB diagnostics.
Specificity
A major advantage of the new serologic tests is the cost and ease of use, Stabel
A sequence analysis showed
says. “Animals can be handled one time to obtain a blood sample rather than
that the MAP1025 gene was presbeing handled twice to administer and read a skin test. That reduces veterinary
ent in the non-MAP strains, which
costs.”—By Sandra Avant, ARS.
did not explain why the antibody
was specific to M. paratubercuJudy Stabel is in the USDA-ARS Infectious Bacterial Diseases Research Unit, Nalosis and not to environmental
tional Animal Disease Center, 1920 Dayton Ave., Ames, IA 50010; (301) 337-7304,
contaminants. To find the answer,
judy.stabel@ars.usda.gov.
Bannantine sequenced MAP1025
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